Charlotta Backman

Charlotta Backman, VP Clinical Operations and Regulatory Affairs, has a strong background in clinical research with 15 years of experience in the start-up, conduct, and close-out of Phase I to Phase IV clinical trials, mostly including trials in oncology and vaccines. Over the years, she has gained experience from interactions with several regulatory authorities in the EU and in the US. Charlotta worked in the CRO industry for Encorium and Remedium, managing clinical trials in various phases and indications before taking on the responsibility for management of the clinical trials with oncolytic adenoviruses at Oncos Therapeutics (later Targovax). Charlotta has a Master’s degree in Cell Biology from Åbo Akademi University. During her academic career, Charlotta worked as a Researcher and Project Team Leader at the University of Helsinki and Folkhälsan Institute of Genetics in the field of disease genetics.